Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Umbro Launch

1 Mar 2023 12:00

RNS Number : 5423R
Versarien PLC
01 March 2023
 

 

 

 

Reach - Non-Regulatory

 

1 March 2023

 

Versarien plc

("Versarien" or the "Company")

Umbro Launch

 

Launch of Umbro's ProTraining Elite range incorporating Versarien's Graphene-Wear™

 

Versarien plc (AIM: VRS), the advanced materials engineering group, is pleased to announce the launch of Umbro's ProTraining Elite range, including garments incorporating the Company's Graphene-Wear™ technology.

 

Versarien has been working with Umbro since 2018 and these are the first products to be launched in Europe incorporating the Company's technology. Umbro's new ProTraining Elite long-sleeve running tops, baselayers and running tights have Versarien's Graphene-Wear™ ink formula printed on the inside. The Graphene-Wear™ formula features novel properties that will allow wearers to experience enhanced thermal transmittance, increased moisture management, with improved drying rate, without compromising air or water vapor permeability. In particular, these three garments will benefit significantly from applying Graphene-Wear™ as they are being worn in circumstances where maintaining core body temperature is more desirable and difficult to achieve. The garments also have Versarien's Graphene-Wear™ trademark applied.

 

In developing its proprietary Graphene-Wear™ technology, Versarien has invested in extensive wearer trials in partnership with University of Gloucestershire and in January 2023 Graphene-Wear™ secured OEKO-TEX® Eco Passport certification, all aimed at giving the Company's partners, such as Umbro, confidence in the technology.

 

Neill Ricketts, Chief Executive Officer of Versarien, said: "We are delighted that Umbro are launching their new Pro-Training Elite range onto the market, incorporating the Company's Graphene-Wear™ technology. This technology is designed to provide the garments with novel properties, in particular regarding their thermo-regulatory properties and the ability to maintain optimum body temperature, that will significantly enhance the user experience.

 

"We look forward to the Umbro ProTraining Elite garments, incorporating Graphene-Wear™, being on sale and it showcasing the viability and attractiveness of using this technology for future products."

 

 

For further information please contact:

 

Versarien Plc

Neill Ricketts - Chief Executive Officer

+44 (0) 1594 887204

Chris Leigh - Chief Financial Officer

Stephen Hodge - Chief Technology Officer

SP Angel Corporate Finance (Nominated Adviser and Joint Broker)

Matthew Johnson, Adam Cowl

+44 (0) 20 3470 0470

Berenberg (Joint Broker)

Mark Whitmore, Ciaran Walsh

+44 (0) 20 3207 7800

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien Plc

 

The strategy of Versarien Plc (AIM:VRS) is to be a globally recognised graphene company with a wide portfolio of high-quality verified materials allied to the largest relevant IP portfolio supported by its own UK based research and development centre driving recurring revenue growth through its innovative graphene product applications.

 

For further information please see: https://www.versarien.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFFLFBXXLXBBE
Date   Source Headline
9th Feb 20267:00 amRNSCancellation - Versarien Plc
6th Jan 20261:34 pmRNSAppointment of Administrators
19th Dec 20254:36 pmRNSUpdate on NOIA
19th Dec 20254:36 pmRNSUpdate on NOIA
15th Dec 20253:53 pmRNSUpdate on the Disposal of AAC Cyroma Limited
12th Dec 20257:00 amRNSUpdate on NOIA and Change of Registered Office
1st Dec 20257:30 amRNSSuspension - Versarien plc
1st Dec 20257:00 amRNSIntention to Appoint Administrators, Suspension
26th Nov 20257:00 amRNSUpdate - Proposed Disposal of the Company's Assets
31st Oct 20258:48 amRNSProposed Disposal of the Company’s Assets
29th Sep 20252:32 pmRNSCorporate Update
10th Sep 20251:00 pmRNSCorporate Update
29th Aug 20252:19 pmRNSCorporate Update
21st Aug 20257:00 amRNSStrategic Investment and Joint Venture Update
11th Aug 20257:00 amRNSCorporate Update
5th Aug 202511:03 amRNSHolding(s) in Company
29th Jul 20257:00 amRNSCorporate Update
22nd Jul 202510:55 amRNSSettlement of Legal Claims
4th Jul 20257:00 amRNS-RSouth American Polygrene™ Themoplastics Agreements
30th Jun 20253:03 pmRNSInterim Results
19th Jun 20252:34 pmRNSBuilding for Humanity – Contract Update
4th Jun 202511:49 amRNSHolding(s) in Company
2nd Jun 20252:03 pmRNSHolding(s) in Company
30th May 202510:19 amRNSHolding(s) in Company
30th May 20257:00 amRNSTotal Voting Rights
29th May 20253:29 pmRNSHolding(s) in Company
29th May 202510:20 amRNSHolding(s) in Company
27th May 202511:59 amRNSHolding(s) in Company
27th May 202511:02 amRNSHolding(s) in Company
23rd May 20259:38 amRNSHolding(s) in Company
22nd May 202511:56 amRNSHolding(s) in Company
21st May 202510:58 amRNSHolding(s) in Company
20th May 202511:11 amRNSHolding(s) in Company
14th May 20257:00 amRNSPlacing to raise £425,000
2nd May 202511:00 amRNSUpdate on Legal Claims
28th Apr 20251:04 pmRNSResult of AGM
27th Mar 20257:00 amRNSAudited Results for year ended 30 September 2024
24th Mar 202511:24 amRNSResult of General Meeting
10th Mar 20257:00 amRNS-RGraphinks™ supply agreement with Montana Química
5th Mar 20257:00 amRNSNotice of General Meeting
3rd Mar 20257:00 amRNSCompletion of Sale of Korean Assets
28th Feb 20257:00 amRNSTotal Voting Rights
27th Feb 20257:00 amRNSInnovate UK Loan Deed of Variation
10th Feb 20258:35 amRNSHolding(s) in Company
28th Jan 20252:36 pmRNSPlacing to raise £246k
30th Dec 202412:00 pmRNSUpdate on Sale of Korean Assets
13th Dec 20242:58 pmRNSHolding(s) in Company
13th Dec 202411:50 amRNSHolding(s) in Company
13th Dec 202410:11 amRNSHolding(s) in Company
13th Dec 20247:00 amRNS€804,000 Grant Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.